Featured Research

from universities, journals, and other organizations

New understanding of resistance to chemotherapy and cancer relapse

Date:
July 12, 2011
Source:
Royal College of Surgeons in Ireland (RCSI)
Summary:
Researchers reveal new insights into how cancer cells can maintain a resistance to chemotherapy resulting in cancer relapse.

Researchers from the Royal College of Surgeons in Ireland (RCSI) have conducted a study which reveals new insights into how cancer cells can maintain a resistance to chemotherapy resulting in cancer relapse. The findings may contribute to improved cancer treatments and better outcomes for patients.

In chemotherapy treatment, anti-cancer drugs are used to kill cancer cells. These drugs trigger a process of programmed cell death (apoptosis) and also impair the function of mitochondria; which are the parts of the cell that regulate the cell's energy production and are essential in maintaining the balance of water and ions, which include substances such as minerals and salts, in the cell (osmotic homeostasis). While apoptosis and impairment of mitochondrial function both lead to cell death, some cancer cells manage to evade both processes to survive the chemotherapy treatment. The study by the RCSI team is the first to reveal the mechanisms by how these cells survive.

The research has shown that chemotherapy resistance is due to a difference in the metabolism which exists in cancer cells compared to normal human cells. In addition to producing energy in the mitochondria, cancer cells can also energy by using glucose in a process known as glycolysis. While it was previously known that this process of glycolysis can restore energy levels in cancer cells being targeted by chemotherapy, this study has revealed that glycolysis also helps to restore mitochondrial function which means that the cancer cells may continue to function following the treatment.

Dr Heinrich Huber, Senior Lecturer at the Department of Physiology and Medical Physics, RCSI commented: "Our findings show that when cancer cells are exposed to elevated glucose levels, mitochondrial function can be restored and osmotic homeostasis can be maintained which contributes to resistance to chemotherapy. Therefore, we have found that in order for cancer treatments to be effective, they must target the cancer cell's ability to produce energy by using glucose within its fluids as well as destroying the mitochondria."

"It is also important that glucose levels in patients are monitored because this can be a factor in resistance to treatment. We hope that our research may inform new potential treatments for cancer." Dr Huber concluded.

Cancer is the second leading cause of death in Ireland with over 16,000 new cases of cancer are diagnosed each year.(1) Current cancer treatments are limited in their effectiveness with poor 5 year survival rates of just 55% reported. (2) Globally, approximately 12.7 million cancers are diagnosed annually (excluding non-melanoma skin cancers and other non-invasive cancers) and 7.6 million people die of cancer worldwide.(3)

Dr Huber was joint lead author of the study with Dr Heiko Dussmann, in collaboration with colleagues Dr Seán Kilbride, Dr Markus Rehm and senior author, Professor Jochen HM Prehn, at the Centre of Human Proteomics and Medical Systems Biology, Department of Physiology and Medical Physics, RCSI.

The research was conducted using a systems biology study that combined computational modelling and live cell microscopy.

The research was published in the scientific journal Molecular Systems Biology(4) and the research team was funded by Science Foundation Ireland, the National Biophotonics and Imaging Platform, the EU Framework Programme 7 and the Health Research Board.

Notes:

(1) National Cancer Registry Ireland 2007 figure for newly diagnosed cancer cases

(2) National Cancer Registry Ireland reports 55.4% five-year survival rates for all cancers excluding non-melanoma skin cancer from 2005-2008

(3) Jemal, A; Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D. "Global cancer statistics." CA: a cancer journal for clinicians. 60:2

(4) Huber HJ, Dussmann H, Kilbride S M, Rehm M, Prehn JHM. Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release. Molecular Systems Biology. 7:470


Story Source:

The above story is based on materials provided by Royal College of Surgeons in Ireland (RCSI). Note: Materials may be edited for content and length.


Cite This Page:

Royal College of Surgeons in Ireland (RCSI). "New understanding of resistance to chemotherapy and cancer relapse." ScienceDaily. ScienceDaily, 12 July 2011. <www.sciencedaily.com/releases/2011/07/110712093841.htm>.
Royal College of Surgeons in Ireland (RCSI). (2011, July 12). New understanding of resistance to chemotherapy and cancer relapse. ScienceDaily. Retrieved July 27, 2014 from www.sciencedaily.com/releases/2011/07/110712093841.htm
Royal College of Surgeons in Ireland (RCSI). "New understanding of resistance to chemotherapy and cancer relapse." ScienceDaily. www.sciencedaily.com/releases/2011/07/110712093841.htm (accessed July 27, 2014).

Share This




More Health & Medicine News

Sunday, July 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) — A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) — The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins